Home Clinical Topics FDA approves new treatment for advanced soft tissue sarcoma

FDA approves new treatment for advanced soft tissue sarcoma

On Oct. 19, the Food and Drug Administration (FDA) approved Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here